Case Discussion: Multiple Sclerosis Flashcards

1
Q

MS

def

A

Multiple sclerosis is a chronic demyelinating disease of adults characterized by multifocal development and accumulation of plaques of demyelination in the CNS. Multiple lesions in time and space is the sine-qua-non of multiple sclerosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MS

Clinical course

A

Extremely Variable:
(1) Classic: acute onset, relapsing/remitting with eventual burn-out of active disease (“RRMS” = relapsing/remitting multiple sclerosis)

(2) Chronic progressive or primary progressive multiple sclerosis (PPMS)
(3) Secondary progressive multiple sclerosis (SPMS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Diagnosis of MS

A

Clinical history and examination: multiple CNS lesions in time and space

CSF examination

(1) mild pleocytosis (5-50 lymphs) during acute attack
(2) increased protein with high IgG
(3) oligoclonal bands (persistent) – Bands seen on electrophoresis of CSF representing antibodies produced within the CNS/CSF

MRI shows multiple plaques, active plaques may enhance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MS

Diagnostic criteria

Pg. 373

A

Do it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MS

Common clinical manifestations

A

i) Optic neuritis: visual loss
ii) Limb weakness
iii) Sensory symptoms (paresthesias, hypesthesia)
iv) Cerebellar ataxia
v) Nystagmus
vi) Diplopia (CN VI palsy or INO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MS

Age of onset/sex/epidemiology

A

Age 15-50, peak in 20’s

F = 2x males

E: temperate climates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MS

genetics

A

(1) Most common in white northern Europeans
(2) Family risk (4% risk of 1st degree relative, 26% monozygotic twin concordance) is most likely due to multiple unlinked genes

(1) Multiple sclerosis incidence increases with latitude
(2) Multiple sclerosis risk correlates with geographic location prior to age 15

Multiple sclerosis incidence correlates with HLA type - MHC locus on chromosome 6, MHC class II HLA-DR2 haplotype DR15, DQ6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MS

Tx

methylprednisone

A

Infusion of high dose methylprednisolone may shorten the course of an acute exacerbation of multiple sclerosis, but probably has no long-term effect on the course of the disease. Monthly infusions are sometimes used in rapidly progressive disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MS

β-interferons

A

Beta-interferons (Betaseron, Avonex, Rebiff) are effective in reducing the severity and frequency of exacerbations

(1) Beta-interferons are thought to interfere with the actions of interferon gamma, which appears to provoke exacerbations
(2) Following binding to specific cellular receptors, interferons lead to synthesis of over 2 dozen proteins that contribute to viral resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MS

Tx

glatiramer

A

Glatiramer (Copaxone) is effective in multiple sclerosis patients and in experimental allergic encephalomyelitis (EAE)

(1) Glatiramer is a mixture of random polymers of four amino acids, L-alanine, L-glutamic acid, L-lysine, and L-tyrosine
(2) The effect is probably related to inhibition of the immune response to myelin basic protein and possibly other myelin antigens
(3) Glatiramer has been shown to at least partially cross-react with myelin basic protein on a cellular and humoral level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MS

Tx

mitoxantrone

A

Mitoxantrone (Novantrone) is effective at slowing the progression of chronic progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis. It is an antibiotic-class antineoplastic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MS

Tx

Natalizumab

A

Natalizumab (Tysabri) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations

(1) Natalizumab is a recombinant humanized immunoglobulin-4 (IgG4) monoclonal antibody produced in murine myeloma cells directed against alpha(4) integrin
(2) Inhibition of alpha(4) integrin results in at least partial blockade of immune-cell adhesion to vascular endothelium and subsequent tissue migration of lymphocytes
(3) May prevent inflammatory cells from crossing the blood-brain barrier
(4) Carries a risk of activating latent JC virus causing fatal progressive multifocal leukoencephalopathy (PML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MS

Tx

Fingolimod

A

Fingolimod is an oral medication indicated to treat relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.

(1) Fingolimod hydrochloride is metabolized (via sphingosine kinase) to the active metabolite fingolimod phosphate, which is a sphingosine 1- receptor modulator. By binding to sphingosine 1-phosphate receptors 1, 3, 4, and 5, fingolimod phosphate prevents lymphocytes from exiting lymph nodes which reduces the lymphocyte count in the peripheral blood. The exact mechanism of action of fingolimod in patients with multiple sclerosis is unknown; however, it may work by reducing lymphocyte migration to the central nervous system.
(2) Bradycardia has been reported and may be asymptomatic; monitoring is recommended for 6 hours after the first dose in all patients or in any patient who discontinued fingolimod for more than 2 weeks and plans to restart it. Atrioventricular block may occur, and blood pressure increases and hypertension have been reported.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neuromyelitis optica

chars

A
Neuromyelitis optica (Devic’s disease) is an inflammatory demyelinating disease that selectively affects optic nerves and spinal cord 
NMO is considered a severe variant of multiple sclerosis (MS) 
Brain lesions develop in 60% of patients with otherwise typical NMO 
A serum immunoglobulin G autoantibody (NMO-IgG) serves as a specific marker for NMO 
NMO-IgG binds selectively to the aquaporin-4 water channel, a component of the dystroglycan protein complex located in astrocytic foot processes at the blood-brain barrier
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Myelinopathies

Basic categories

A

Primary: disease process directly affects myelin or myelin-producing cell

Secondary: myelin loss or damage is secondary to damage to axon or neuron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MS

variants

A

Subclinical/self-limited
Acute fulminant (Marburg variant)
Childhood onset with massive demyelination
Neuromyelitis optica (devic variant: SC, optic nerves)

17
Q

Diseases affecting myelin

Immune-mediated

A

MS

Acute disseminated encephalomyelitis

AIDP

CIDP

18
Q

Classifications of myelinopathy

viral

A

PML

19
Q

Classifications of myelinopathy

Toxic/metabolic damage

A

Central pontine myelinolysis

Radiation-induced leukoencephalopathy

Demyelinating peripherals neuropathies due to therapeutic drugs

Lead poisoning

20
Q

Classifications of myelinopathy

Vascular (genetic)

A

CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts + leukoencephalopathy)

21
Q

Classifications of myelinopathy

Inheritied metabolic

A

Leukodystrophies

Many more

22
Q

Chars of MS plaques

A

Discrete foci of primary demyelination, not defined by anatomic system:
Demyelination is usually complete
Plaques are usually perivenous

23
Q

MS plaques

Areas of predilection

A

Periventricular white matter

Subpial white matter (SC, optic pathways)

Gray-White Junction

24
Q

MS

Evolution of inflammatory lesion

A

Individual plaque: acute → resolving → gliotic

Possible fate of acute plaque:
Partial remyelination
Enlargement
Evolution into chronic lesion with oligo/axonal loss
Burn out phase: demyelinated glial scar
25
Q

MS

CSF findings

A

Increased protein

↑IgG, oligoclonal bands

26
Q

Diseases with similar pathology to acute MS

A

Experimental allergic encephalomyelitis (animal)

Acute Disseminated encephalomyelitis
Acute monophasic disease usually triggered by systemic viral infections or immunization

27
Q

PML vs MS

plaques

A

Lesions may mimic MS plaques but are more destructive and do not enhance

28
Q

Central pontine myelinolysis

def

A

Acute destructive disease affecting myelin due to over rapid correction of hyponatremia

29
Q

Central pontine myelinolysis

Pathology/clinical manifestations

A

P: Localized breakdown of myelin, usually in midline of basis pontis

CM: rapidly evolving quadriplegia due to bilateral damage to corticospinal tract myelin

30
Q

Leukodystrophies

def

A

Group of rare inherited diseases, whose principal manifestations are due to damage to myelin

31
Q

Leukodystrophies

Clinical features

A

-Most are autosomal recessive, have an early onset, and are eventually lethal

Subgroups:
Normal early neurological development followed by loss of milestones and neurological regression
Abnormal neurologic development

32
Q

Leukodystrophies

pathology

A

usually results in diffuse, symmetric white matter damage

33
Q

Leukodystrophies

classification

A

Defects of myelin degredative enzymes (LSD):
Metachromatic leukodystrophy
Krabbes globoid cell leukodystrophy

Defects of molecules forming myelin (dysmyelinating diseases):
Pelizaeus-merzbacher disease

Others:
Canavans disease
Alexanders disease

34
Q

Major patterns of primary myelin disease

list

A

MS pattern (randomly scattered plaques in CNS)

ADEM/AIDP patterns (numerous tiny foci)

Leukodystrophy pattern (diffuse symmetrical)